Showing 1771-1780 of 2739 results for "".
Molluscum: Challenges and a Promising Solution
https://practicaldermatology.com/topics/rare-disease/molluscum-challenges-and-a-promising-solution/23532/Molluscum is under-diagnosed and under-treated in the US, but a new treatment could change that.What’s Really in a “Collagen” Supplement?
https://practicaldermatology.com/youngmd-connect/resident-resource-center/whats-really-in-a-collagen-supplement/23579/Concerns about lack of transparency of sourcing, potential for allergic reactions, and reports of contamination have been associated with collagen supplements.Diverse by Design: The Unique Molecular Footprints of IL-23 Biologics in Psoriasis
https://practicaldermatology.com/issues/april-2024/il23_biologics_in_psoriasis/24457/Christopher Bunick, MD, PhD, discusses a study that explores the structural basis of IL-23 targeted biologic therapies for psoriasis. By mapping the binding sites of these therapies on the IL-23 molecule and correlating molecular properties with clinical efficacy, the study offers insights into whyGLP-1 Receptor Agonists and the Aesthetic Patient: Considerations for the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-and-the-aesthetic-patient/48900/The impact of glucagon-like peptide-1 agonists (GLP-1), such as semaglutide, tirzepatide and liraglutide, has transformed the healthcare industry and, in particular, aesthetic dermatology. The most common intended use of these medications, namely diabetes management and weight loss, can lead to a muOpen Payments Program: Does it Enhance Open Discussion About Financial Ties Between Dermatologists and Industry?
https://practicaldermatology.com/youngmd-connect/resident-resource-center/open-payments-program-does-it-enhance-open-discussion-about-financial-ties-between-dermatologists-and-industry/23619/The majority of physicians practicing in the United States have received some form of compensation from private industry during their careers. These payments may include consulting fees, compensation for speaking engagements, and stock options. Certain payments take indirect forms, such as physicAGEP Following a New Weight Loss Regimen
https://practicaldermatology.com/youngmd-connect/resident-resource-center/agep-following-a-new-weight-loss-regimen/23719/A 55-Year-Old Man with Erythematous Papules Following a New Weight Loss RegimenDo You Own Real Estate in Your Practice?
https://practicaldermatology.com/topics/practice-management/do-you-own-real-estate-in-your-practice/20783/Five tips for dermatologists considering the sale of real estate to REIT.The Dermatology Problem List; Calling Residents; CSF Grants Available
https://practicaldermatology.com/youngmd-connect/resident-resource-center/the-dermatology-problem-list-calling-residents-csf-grants-available/20938/New Products
https://practicaldermatology.com/columns/new-products/newproducts/21023/A Rare Case of Linear Darier Disease
https://practicaldermatology.com/youngmd-connect/resident-resource-center/a-rare-case-of-linear-darier-disease/23857/A localized genodermatosis with potential to cause widespread disease in the next generation.